CD19 CAR circRNA, expressing CD19 car protein, is utilized in chimeric antigen receptor T cell immunotherapy (CAR-CD19). This compound involves a chimeric antigen receptor, CD19, a CD molecule present on B cells (i.e., leukocyte differentiation antigen),
Purity:
98.00%
* VAT and and shipping costs not included. Errors and price changes excepted